In two elegant studies, Tyler Jacks’ group and colleagues unveil crucial interactions between dendritic cells and TCF1+CD8+ progenitor T cells, shaping their heterogeneity and offering potential to design new putative cancer immunotherapies and vaccines.
Funding
The authors were supported by Victorian Cancer Agency Fellowship MCRF18027 and National Health and Medical Research Council of Australia Ideas Grant APP1185513 awarded to L.A.M.